Compare Medpace Holdings Inc (MEDP) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vanguard Ultra Short Bond ETF — how do they compare? Medpace Holdings Inc trades at $601 (market cap $16.66B), while Vanguard Ultra Short Bond ETF trades at $49.69. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | VUSB | |
|---|---|---|
Market Cap | $16.66B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $620.59 | $50.03 |
52-Week Low | $393.42 | $49.60 |
Enterprise Value | $16.28B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.
MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.
VUSB trades at $49.68 with minimal daily movement (+0.04%). The technical picture is bearish with moving averages signaling selling pressure, though oscillators remain neutral. Recent dividend distributions show consistent payouts, with the latest being $0.18 paid on July 6, 2026. Financial ratios are unavailable in the current data snapshot.
The outlook remains cautious due to bearish technical indicators and potential interest rate sensitivity. Recent financial media suggests short-term bond ETFs like VUSB may benefit from Fed rate increases in 2026, though the current technical weakness warrants careful monitoring of support levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vanguard Ultra Short Bond ETF
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →
